AAV Capsid Separation by Stepwise Conductivity Elution
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for separating empty and full adenovirus-associated virus (AAV) particles are difficult to scale and do not provide a consistent, high-quality product for gene therapy due to inefficiencies in existing separation techniques like density gradient ultracentrifugation and column chromatography.
Innovation Solution
An anion exchange chromatography method using a step gradient conductivity increase from 0.5 to 20 mS/cm to separate full AAV capsids from empty AAV capsids, utilizing an equilibration buffer and a salt-containing buffer with specific pH and conductivity ranges, suitable for various serotypes and variants.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If density gradient ultracentrifugation or column chromatography is used to separate empty and full AAV particles, then separation is achieved, but the method is difficult to operate on a large scale with improved separation
Solution Approach 1:
The invention changes the conductivity parameter in a stepwise manner during elution, using discrete conductivity steps (e.g., 0.5 mS/cm, 1.0 mS/cm, 1.5 mS/cm, etc.) rather than continuous gradient or constant conductivity. This parameter change enables both high separation quality and scalability to large-scale manufacturing
Solution Approach 2:
The invention uses a dynamic elution process where conductivity is progressively increased in controlled steps during the chromatography run. This dynamic adjustment of conductivity allows optimization of separation at each stage while maintaining scalability across different production volumes
2Reliability
If current separation methods are used, then empty and full AAV particles can be separated, but the product consistency and quality are not sufficient for gene therapy
Solution Approach 1:
The invention segments the elution process into multiple discrete conductivity steps, where each step targets specific AAV particle populations. This segmentation allows precise control over separation quality and consistent enrichment of full AAV particles, achieving both high manufacturing precision and reliable product consistency
Solution Approach 2:
The invention uses UV absorbance monitoring at 260 nm and 280 nm to detect eluting AAV particles in real-time, with the conductivity steps designed to correspond with detected peaks. This feedback mechanism ensures consistent separation quality and reliable product enrichment across multiple batches
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves consistent enrichment of full AAV capsids, providing a higher quality therapeutic agent by effectively separating empty and full AAV particles, suitable for large-scale manufacturing and serotype-independent use.
Implementation Method 1
subjecting the sample to anion exchange chromatography with an elution buffer comprising an equilibration buffer and a salt-containing buffer
Implementation Method 2
anion exchange chromatography...to elute empty AAV capsids and to provide a fluid enriched with full AAV capsids
Implementation Method 3
changing the ratio of the equilibration buffer and the salt-containing buffer to provide a step gradient conductivity increase of about 0.5-2.0 mS/cm in each step to elute empty AAV capsids
Data Source
AI summary
Provided is a method of enriching full adenovirus-associated virus (AAV) capsids from a mixture of full AAV capsids and empty AAV capsids, the method comprising providing a sample comprising a mixture of full AAV capsids and empty AAV capsids, subjecting the sample to anion exchange chromatography comprising an elution buffer comprising an equilibration buffer and a salt-containing buffer in an initial ratio that provides an initial conductivity, and changing the ratio of the equilibration buffer and the salt-containing buffer to provide a step gradient conductivity increase of about 0.5-2.0 mS/cm in each step to elute empty AAV capsids and to provide a fluid enriched with full AAV capsids.